Literature DB >> 16181383

Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa.

Francesco Paparo1, Emma Petrone, Antonella Tosco, Maria Maglio, Melissa Borrelli, Virginia M Salvati, Erasmo Miele, Luigi Greco, Salvatore Auricchio, Riccardo Troncone.   

Abstract

BACKGROUND: Antiendomysium antibodies have a high sensitivity and specificity for celiac disease. A small percentage of subjects positive for these antibodies have a small intestinal mucosa hitherto considered normal.
OBJECTIVES: The aim of this study was to characterize the clinical, serological, immunogenetic, and immunohistological features of these subjects.
METHODS: From 409 patients who were positive for celiac-related antibodies, we selected 24 (5.9%) patients who had an architecturally normal small intestinal mucosa. One hundred age-matched celiac patients with a "flat" small intestinal mucosa, and 50 age-matched nonceliac children were also studied. The number of CD3+ and gammadelta+ intraepithelial lymphocytes and of CD25+ lamina propria mononuclear cells, and the expression of crypt HLA-DR and lamina propria ICAM-1 were assessed. HLA haplotyping was also performed.
RESULTS: Eleven (45.8%) of the 24 patients had a distinct infiltrative pattern, i.e., an increase in CD3+ intraepithelial lymphocytes (> 2SD of the nonceliac group), whereas 17 (70.8%) had a higher density of intraepithelial gammadelta+ cells. In 17 (70.8%) patients, the number of lamina propria CD25+ cells was increased and/or the expression of ICAM-1 and crypt HLA-DR was enhanced. All 24 patients carried the celiac disease-associated HLA haplotypes. Two of the six patients who remained on a normal diet and underwent a second jejunal biopsy developed villous atrophy.
CONCLUSIONS: Most of the patients with serum antiendomysium antibodies and normal jejunal histology showed immunohistochemical signs of immune activation in the epithelium, lamina propria, and crypts. We recommend that such patients be monitored to assess their progress and to determine whether they need a gluten-free diet.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181383     DOI: 10.1111/j.1572-0241.2005.41134.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  29 in total

Review 1.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

Review 2.  Celiac disease: diagnostic criteria in progress.

Authors:  U Volta; V Villanacci
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

3.  Latent coeliac disease or coeliac disease beyond villous atrophy?

Authors:  Katri Kaukinen; Pekka Collin; Markku Mäki
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

4.  Anti-TCR gamma antibody in celiac disease: the value of count on formalin-fixed paraffin-embedded biopsies.

Authors:  Silvia Lonardi; Vincenzo Villanacci; Luisa Lorenzi; Alberto Lanzini; Francesco Lanzarotto; Nice Carabellese; Umberto Volta; Fabio Facchetti
Journal:  Virchows Arch       Date:  2013-07-17       Impact factor: 4.064

5.  Recent advances in celiac disease.

Authors:  Hugh James Freeman; Angeli Chopra; Michael Tom Clandinin; Alan Br Thomson
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

Review 6.  Celiac disease in type 1 diabetes mellitus.

Authors:  Maria Erminia Camarca; Enza Mozzillo; Rosa Nugnes; Eugenio Zito; Mariateresa Falco; Valentina Fattorusso; Sara Mobilia; Pietro Buono; Giuliana Valerio; Riccardo Troncone; Adriana Franzese
Journal:  Ital J Pediatr       Date:  2012-03-26       Impact factor: 2.638

7.  In the Intestinal Mucosa of Children With Potential Celiac Disease IL-21 and IL-17A are Less Expressed than in the Active Disease.

Authors:  Melissa Borrelli; Carmen Gianfrani; Giuliana Lania; Rosita Aitoro; Katia Ferrara; Merlin Nanayakkara; Domenico Ponticelli; Delia Zanzi; Valentina Discepolo; Serena Vitale; Maria Vittoria Barone; Riccardo Troncone; Renata Auricchio; Mariantonia Maglio
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

8.  Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.

Authors:  A Tosco; R Auricchio; R Aitoro; D Ponticelli; M Primario; E Miele; V Rotondi Aufiero; V Discepolo; L Greco; R Troncone; M Maglio
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

9.  Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine.

Authors:  Mariantonia Maglio; Fiorella Florian; Monica Vecchiet; Renata Auricchio; Francesco Paparo; Raffaella Spadaro; Delia Zanzi; Luciano Rapacciuolo; Adriana Franzese; Daniele Sblattero; Roberto Marzari; Riccardo Troncone
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

10.  Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa.

Authors:  Jonas F Ludvigsson; Lena Brandt; Scott M Montgomery
Journal:  BMC Gastroenterol       Date:  2009-07-22       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.